Alan Talevi

ORCID: 0000-0003-3178-826X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Computational Drug Discovery Methods
  • Drug Transport and Resistance Mechanisms
  • Pharmacological Effects and Toxicity Studies
  • Pharmacogenetics and Drug Metabolism
  • Drug Solubulity and Delivery Systems
  • Epilepsy research and treatment
  • Advanced Drug Delivery Systems
  • Trypanosoma species research and implications
  • Pharmaceutical studies and practices
  • Neuroscience and Neuropharmacology Research
  • Analytical Chemistry and Chromatography
  • Synthesis and Biological Evaluation
  • Amino Acid Enzymes and Metabolism
  • Research on Leishmaniasis Studies
  • Chemical Synthesis and Analysis
  • Nanoparticle-Based Drug Delivery
  • Biochemical Analysis and Sensing Techniques
  • Metabolism and Genetic Disorders
  • Crystallization and Solubility Studies
  • Machine Learning in Materials Science
  • Synthesis and biological activity
  • Protein Interaction Studies and Fluorescence Analysis
  • Bioinformatics and Genomic Networks
  • Receptor Mechanisms and Signaling
  • Pharmaceutical Economics and Policy

Universidad Nacional de La Plata
2016-2025

Exact Sciences (United States)
2025

Centro Científico Tecnológico - La Plata
2011-2024

Nanyang Technological University
2024

Consejo Nacional de Investigaciones Científicas y Técnicas
2008-2024

Massachusetts Institute of Technology
2024

National Cancer Institute
2024

Biochemistry Research Institute of La Plata
2022

Centro Científico Tecnológico - San Juan
2019-2022

Centro de Investigación y Desarrollo
2017

Multi-target drugs have raised considerable interest in the last decade owing to their advantages treatment of complex diseases and health conditions linked drug resistance issues. Prospective repositioning treat comorbid is an additional, overlooked application multi-target ligands. While medicinal chemists usually rely on some version lock key paradigm design novel therapeutics, modern pharmacology recognizes that mid- long-term effects a given biological system may depend not only...

10.3389/fphar.2015.00205 article EN cc-by Frontiers in Pharmacology 2015-09-22

Artificial intelligence, in particular machine learning (ML), has emerged as a key promising pillar to overcome the high failure rate drug development. Here, we present primer on ML algorithms most commonly used discovery and We also list possible data sources, describe good practices for model development validation, share reproducible example. A companion article will summarize applications of discovery, development, postapproval phase.

10.1002/psp4.12491 article EN cc-by-nc CPT Pharmacometrics & Systems Pharmacology 2020-01-06

The scientific community is working against the clock to arrive at therapeutic interventions treat patients with COVID-19. Among strategies for drug discovery, virtual screening approaches have capacity search potential hits within millions of chemical structures in days, appropriate computing infrastructure. In this article, we first analyzed published research targeting inhibition main protease (Mpro), one most studied targets SARS-CoV-2, by docking-based methods. An alarming finding was...

10.1021/acs.jcim.1c00404 article EN Journal of Chemical Information and Modeling 2021-07-27

10.1007/978-1-4939-7756-7_1 article EN Methods in molecular biology 2018-01-01

Introduction: Drug repositioning implies finding new medical uses for existing drugs. It represents a cost-efficient approach, since the indications are built on basis of available information pharmacokinetics, safety and manufacturing. Whereas most pioneering drug repurposing stories arose from serendipitous observations clever exploitation side effects, discovery community has lately addressed initiatives in more systematic manner. Today, middle omics era, we have tools to explore...

10.1080/23808993.2018.1424535 article EN Expert Review of Precision Medicine and Drug Development 2018-01-02

Purpose: Optimizing brain bioavailability is highly relevant for the development of drugs targeting central nervous system. Several pharmacokinetic parameters have been used measuring drug in brain. The most biorelevant among them possibly unbound brain-to-plasma partition coefficient, Kp uu,brain,ss , which relates and plasma concentrations under steady-state conditions. In this study, we developed new silico models to predict . Methods: A manually curated 157-compound dataset was compiled...

10.3389/fddsv.2024.1360732 article EN cc-by Frontiers in Drug Discovery 2024-04-04

Cruzipain (Cz) is the major cystein protease of protozoan Trypanosoma cruzi, etiological agent Chagas disease. From a 163 compound data set, 2D-classifier capable identifying Cz inhibitors was obtained and applied in virtual screening campaign on DrugBank database, which compiles FDA-approved investigational drugs. Fifty-four approved drugs were selected as candidates, four acquired tested T. cruzi epimastigotes. Among them, antiparkinsonian antidiabetic drug bromocriptine antiarrhythmic...

10.1021/ci400284v article EN Journal of Chemical Information and Modeling 2013-08-01

Malaria is among the leading causes of death worldwide. The emergence Plasmodium falciparum resistant strains with reduced sensitivity to first line combination therapy and suboptimal responses insecticides used for Anopheles vector management have led renewed interest in novel therapeutic options. Here, we report development validation an ensemble ligand-based computational models capable identifying falcipain-2 inhibitors, their subsequent application virtual screening DrugBank Sweetlead...

10.3389/fchem.2019.00534 article EN cc-by Frontiers in Chemistry 2019-08-06

The clustering of small molecules implies the organization a group chemical structures into smaller subgroups with similar features. Clustering has important applications to sample datasets or libraries in representative manner (e.g., choose, from virtual screening hit list, chemically diverse subset compounds be submitted experimental confirmation, split training and validation sets when implementing machine learning models). Most strategies for are based on molecular fingerprints...

10.1021/acs.jcim.2c00265 article EN Journal of Chemical Information and Modeling 2022-06-10
Coming Soon ...